In April 2014, the number of shares in Recipharm has increased by 10,443,038 shares of series B, corresponding to 10,443,038 votes, as a result of two new issues made in connection with Recipharm’s IPO and subsequent listing on NASDAQ OMX Stockholm. Furthermore, during the same period, 1,374,407 shares of series C have been issued in connection with the conversion of outstanding convertible bonds in Recipharm. These shares of series C have been converted into shares of series B. In total, 97.8 percent of the convertible bonds have been converted into shares. As of 30 April 2014, the share capital in Recipharm amounts to SEK 18,594,437.50, divided into 12,685,716 shares of series A and 24,503,159 shares of series B. The total number of votes in Recipharm as of 30 April 2014 amounts to 151,360,319. This information is published in accordance with Chapter 4, Section 9 of the Financial Instruments Trading Act (1991:980). For further information please visit www.recipharm.com or contact: Thomas Eldered, CEO, thomas.eldered@recipharm.com, telephone: +46 8 602 52 10 Björn Westberg, CFO, bjorn.westberg@recipharm.com, telephone: +46 8 602 46 20 This information is published in accordance with the Swedish Securities Market Act, the Swedish Financial Instruments Trading Act and/or the regulations of NASDAQ OMX Stockholm. This information was submitted for publication on 30 April, 2014, at 12.00 pm CET. Recipharm AB (publ) Corporate identity number 556498-4825 Street address Lagervägen 7, Jordbro Telephone +46 8 602 52 00 Postal address Lagervägen 7, SE-136 50 Jordbro Fax +46 8 81 87 03 www.recipharm.com About Recipharm Recipharm is a leading CDMO (Contract Development and Manufacturing Organisation) in the pharmaceutical industry based in Sweden employing some 1,500 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and pharmaceutical product development. Recipharm currently manufactures more than 200 different products to both Big Pharma and smaller research- and development companies. Recipharm’s turnover is approximately SEK 2.1 billion and the Company operates development and manufacturing facilities in Sweden, France, the UK, Germany and Spain and is headquartered in Jordbro, Sweden. The Recipharm B-share (RECI B) is listed on Nasdaq OMX Stockholm.
Change in the total number of shares and votes in Recipharm
Top 10 Most Recent News Articles
Stellus Capital Delivers Solid Q3 Amid Turbulent Times
Unpacking Stellus Capital's Latest Quarter Boy, Stellus Capital sure knows how to keep us on our toes. In a landscape where many are still reeling from the latest market tremors, they post some solid Q3 numbers for September 30, 2026. Not without its hiccups, but hey, who isn’t stumbling a bit right now? Financial Snapshot: Stability Amidst Uncertainty Stellus reported...
Continue Reading
Safeguard Global Scores with Atlético Partnership
Kicking Off a New Chapter in Workforce Management Well, when a global workforce giant teams up with a football powerhouse like Atlético de Madrid, it sure does mark a significant play on the field of employment strategies. Safeguard Global has just inked a multi-year partnership with Atlético, signing on as their Official Workforce Partner in Spain. It's not every day...
Continue Reading
Americans Grapple with Stagnant Personal Finances: Survey
Americans' Financial Struggles Uncovered The economic landscape seems like a grizzled veteran who's seen its fair share of battles, but lately, it's been hitting families square in the wallet. According to Achieve's latest survey, a stark 71% of Americans are staring at finances that are either stuck in neutral or sliding backwards. Less than half say they’re in a good...
Continue Reading
Daycare Drama: Lawsuit Over Child in Traffic Incident
When Chaos Meets Daycare Negligence Fort Worth is no stranger to wild stories, but when a daycare loses a child, you've got a whole different beast. Picture this: a 2-year-old girl, barely tall enough to peek over her own shadow, found by herself on a high-traffic road. That's not just someone's bad day—it's a lawsuit waiting to explode. And boy, has it ever. Parents...
Continue Reading
Texas Author's Memoir Journeys Through Trauma and Growth
Finding Clarity Amid Chaos When life throws the unexpected, some folks crumble, but others, like Joyce L. Skala, sift through the rubble for clarity. Her debut memoir, "There's No Such Thing as Bad," weaves through personal chaos—embracing trauma and loss like a late-night poker game where the house always wins. Born from the charred memories of her family's home...
Continue Reading
Quest Diagnostics at Jefferies Conference: What’s Next?
Quest Diagnostics Set for the Spotlight in London You're sipping your morning coffee when you hear that Quest Diagnostics (NYSE: DGX) is gearing up for a fireside chat in the UK's capital. Now, this isn't a random chit-chat we're talking about. Sam Samad, the man handling the books as their CFO, will be chatting it up at the Jefferies Global Healthcare Conference on...
Continue Reading
Marketing Maven Hosts Claude Workshop for Small Biz
Diving into Claude for Business Out in Ventura County, California, there's a buzz about a fresh, no-cost workshop on deck. Marketing Maven's Lindsey Carnett and Design Main Street's Will Hsiao are teaming up to crack open the potential of Claude for small businesses. And let me tell you, this ain't your typical Monday seminar—it's setting up to provide the golden...
Continue Reading
Spotlight on Shenzhen: Malcolm Clarke Unveils a New Lens
A Fresh Gaze on Shenzhen's Dynamic Pulse When's the last time a glossy documentary slapped you awake? That's the vibe Oscar-winning filmmaker Malcolm Clarke is gunning for with his latest, Shenzhen: People Who Build the Future. Forget the cookie-cutter skyline shots, this one's peeling back layers and going beyond the surface gloss. From Pioneers to Futurists: Shenzhen's...
Continue Reading
Mesh Security Bolsters Team with Five Cybersecurity Experts
New Blood in Cybersecurity: Mesh's Strategic Moves Ever felt like the cybersecurity world is in a constant game of catch-up? You're not wrong. In today's digital battleground, companies don't just need more tools—they need collective wisdom to bind it all together. And it seems like Mesh Security just caught onto that notion, stacking their deck with five new...
Continue Reading
FuelCell Energy Class Action Deadline Looms Amid Loss Reports
November Deadline for FCEL Class Action Participation You've probably seen the stars align in all the wrong ways if you've got stakes in FuelCell Energy, Inc. (NASDAQ: FCEL) right now. A class action lawsuit is breathing down everyone's neck, with a cut-off date of November 10, 2026, to hop aboard. If you bought into FuelCell between June 24 and September 1 of this year,...
Continue ReadingTop 5 Most Recently Viewed Articles
HIKMICRO Unveils Innovative Thermal Monoculars for Hunters
HIKMICRO Unveils Innovative Thermal Monoculars for Hunters DORTMUND, GERMANY — HIKMICRO, a trailblazer in the optics industry, is gearing up to showcase its latest advancements in thermal monoculars at the upcoming JAGD & HUND Dortmund event. Marking a significant enhancement in hunting technology, the company emphasizes its commitment to innovation with two flagship...
Continue Reading
FDA Nod for Eli Lilly's EBGLYSS: A Game-Changer?
Regulatory Green Light for EBGLYSS There's no denying it, sometimes news hits like a well-placed punch, and the FDA approval for Eli Lilly's (NYSE: LLY) EBGLYSS to be dosed every eight weeks for moderate-to-severe atopic dermatitis is one of those punches. This approval could be a significant moment for both patients and investors, shaking up the treatment landscape. Why...
Continue Reading
Latin Metals Uncovers Visible Gold at La Flora Project Site
Latin Metals Explores La Flora Gold Discovery VANCOUVER, British Columbia — Latin Metals Inc. ("Latin Metals" or the "Company") - (TSXV: LMS) (OTCQB: LMSQF) is excited to share updates on its exploration progress at its notable La Flora project. This undertaking has unveiled visible gold within the project area, marking a significant milestone for the Company. Exciting...
Continue Reading
C2C Metals Expands Uranium Holdings with New Mining Claims
C2C Metals Corp Expands Uranium Portfolio C2C Metals Corp (CSE: CTOC, OTCQB: CTCGF) recently announced an exciting move for its growth strategy by acquiring five uranium-vanadium properties in the renowned Uravan Mining District. This acquisition encompasses about 5,400 acres or roughly 8.4 square miles, primarily situated within the Colorado region of the district. The...
Continue Reading
Analyzing Current Market Trends for Robinhood Markets Stock
Understanding the Current Options Activity for Robinhood Markets Investment patterns for Robinhood Markets are currently leaning towards a bearish outlook among significant capital investors. This shift is notable for retail traders who need to stay informed. Today, we have observed this emerging trend through the options history, showcasing some striking trading activity...
Continue Reading